EW

EW Change in Working Capital

-$31.80MTTM · USD

Period ending:

EW FY Change in Working CapitalUSD
EW FY Change in Working Capital1999-12-31: -$1.00M2000-12-31: -$12.00M2001-12-31: -$5.00M2002-12-31: -$36.30M2003-12-31: -$19.90M2004-12-31: $2.80M2005-12-31: -$3.60M2006-12-31: -$14.90M2007-12-31: $4.10M2008-12-31: -$69.50M2009-12-31: -$68.30M2010-12-31: -$1.10M2011-12-31: -$29.70M2012-12-31: $11.50M2013-12-31: $21.50M2014-12-31: $190.30M2015-12-31: $64.40M2016-12-31: $66.10M2017-12-31: $234.20M2018-12-31: -$42.60M2019-12-31: -$204.30M2020-12-31: $42.20M2021-12-31: $145.30M2022-12-31: -$421.40M2023-12-31: -$526.30M2024-12-31: -$259.30M2025-12-31: $154.60M$234.20M-$526.30M
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

EW change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Edwards Lifesciences Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
154,600,000
-259,300,000
-526,300,000
-421,400,000
145,300,000
42,200,000
-204,300,000
-42,600,000
234,200,000
66,100,000
64,400,000
190,300,000
21,500,000
11,500,000
-29,700,000
-1,100,000
-68,300,000
-69,500,000
4,100,000
-14,900,000
-3,600,000
2,800,000
-19,900,000
-36,300,000
-5,000,000
-12,000,000
-1,000,000

Compare change in working capital

All EW financial metrics · EW stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.